Literature DB >> 16796814

Methylene blue inhibits angiogenesis in chick chorioallontoic membrane through a nitric oxide-independent mechanism.

N Zacharakis1, P Tone, C S Flordellis, M E Maragoudakis, N E Tsopanoglou.   

Abstract

Angiogenesis is the process of generating new blood vessels from preexisting vessels and is considered essential in many pathological conditions. The purpose of the present study was to evaluate the effect of methylene blue in chick chorioallantoic membrane angiogenesis model in vivo. In this well characterized model, methylene blue inhibited angiogenesis in a concentration-dependent manner. In addition, when methylene blue was combined with sodium nitroprusside, a spontaneous generator of nitric oxide, an inhibition of angiogenesis was evident which was comparable with that observed by the application of methylene blue alone. Sodium nitroprusside, alone, caused a significant inhibition in basal angiogenesis. These results provide evidence that methylene blue inhibits angiogenesis independently of nitric oxide pathway and suggest that methylene blue may be useful for treating angiogenesis-dependent human diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16796814      PMCID: PMC3933136          DOI: 10.1111/j.1582-4934.2006.tb00414.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  27 in total

Review 1.  Regulators of angiogenesis and strategies for their therapeutic manipulation.

Authors:  Malgorzata Milkiewicz; Eric Ispanovic; Jennifer L Doyle; Tara L Haas
Journal:  Int J Biochem Cell Biol       Date:  2005-11-07       Impact factor: 5.085

2.  Methylene blue in anaphylactic shock.

Authors:  P R Evora; C H Roselino; P M Schiaveto
Journal:  Ann Emerg Med       Date:  1997-08       Impact factor: 5.721

Review 3.  Methemoglobinemia: etiology, pharmacology, and clinical management.

Authors:  R O Wright; W J Lewander; A D Woolf
Journal:  Ann Emerg Med       Date:  1999-11       Impact factor: 5.721

4.  YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models.

Authors:  Shiow-Lin Pan; Jih-Hwa Guh; Chieh-Yu Peng; Shih-Wei Wang; Ya-Ling Chang; Fong-Chi Cheng; Jau-Hsiang Chang; Sheng-Chu Kuo; Fang-Yu Lee; Che-Ming Teng
Journal:  J Pharmacol Exp Ther       Date:  2005-03-22       Impact factor: 4.030

5.  An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

6.  TNP-470 inhibits intraabdominal adhesion formation.

Authors:  S C Chiang; C H Cheng; K S Moulton; J M Kasznica; S L Moulton
Journal:  J Pediatr Surg       Date:  2000-02       Impact factor: 2.545

7.  Thrombin promotes angiogenesis by a mechanism independent of fibrin formation.

Authors:  N E Tsopanoglou; E Pipili-Synetos; M E Maragoudakis
Journal:  Am J Physiol       Date:  1993-05

8.  Validation of collagenous protein synthesis as an index for angiogenesis with the use of morphological methods.

Authors:  M E Maragoudakis; G C Haralabopoulos; N E Tsopanoglou; E Pipili-Synetos
Journal:  Microvasc Res       Date:  1995-09       Impact factor: 3.514

9.  Inhibition of nitric oxide synthesis by methylene blue.

Authors:  B Mayer; F Brunner; K Schmidt
Journal:  Biochem Pharmacol       Date:  1993-01-26       Impact factor: 5.858

10.  A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures.

Authors:  R W Farndale; C A Sayers; A J Barrett
Journal:  Connect Tissue Res       Date:  1982       Impact factor: 3.417

View more
  3 in total

1.  Therapeutic approaches to delay the onset of Alzheimer's disease.

Authors:  Raj Kumar; Hani Atamna
Journal:  J Aging Res       Date:  2011-03-03

Review 2.  The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis.

Authors:  Domenico Ribatti
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-08

Review 3.  Pharmacological treatment for hepatopulmonary syndrome.

Authors:  Ahad Eshraghian; Amir A'lam Kamyab; Seung Kew Yoon
Journal:  Biomed Res Int       Date:  2013-09-12       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.